HDAC9 and chronic obstructive pulmonary disease: To assess whether butyrate behaves as an HDAC inhibitor in ILC2s, sorted lung ILC2s from the control, as well as COPD with control diet, Hi-Cellulose, and Hi-Pectin mice and associated H3 acetylation, were closely evaluated.